Financhill
Back

Crinetics Pharmaceuticals Stock Predictions

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis: See What Your Stock is Really Worth

Analyze Any Stock Free

Crinetics Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 24% based on the past 6 years of stock performance.
  • Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Crinetics Pharmaceuticals Stock Undervalued?
    The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Crinetics Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 24% based on the past 6 years of stock performance.

Crinetics Pharmaceuticals Stock Rating

Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals overpriced?

  • Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Crinetics Pharmaceuticals Stock Price History

Is CRNX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crinetics.com

52-Week Data

52-Week High:
62.53
52-Week Low:
35.24

Prediction Charts

Market Cap:
3.8B
Price in USD:
48.50
Volume:
760K
Beta:
0.69

Technical Analysis

SMA50:
55.63
SMA100:
54.48
SMA200:
51.03
52-Wk Change:
34.91%

Stock Predictions

  • Is Crinetics Pharmaceuticals stock public?
    Yes, Crinetics Pharmaceuticals is a publicly traded company.
  • What is the Crinetics Pharmaceuticals stock quote today?
    The Crinetics Pharmaceuticals stock price is 48.50 USD today.
  • How to buy Crinetics Pharmaceuticals stock online?
    You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 55.45 52.09 55.47 51.35
Dec-19 52.08 52.74 53.05 50.82
Dec-20 52.28 53.50 54.25 51.73
Dec-23 53.22 53.96 54.09 52.47
Dec-24 53.93 53.94 54.78 53.15
Dec-26 53.36 53.92 54.18 52.88
Dec-27 53.05 51.85 53.66 51.55
Dec-30 51.15 50.67 51.28 50.50
Dec-31 51.14 51.13 52.09 50.43
Jan-2 51.90 51.55 52.51 51.09
Jan-3 51.67 53.15 53.55 51.60
Jan-6 53.22 50.49 53.41 50.31
Jan-7 50.71 49.42 51.06 49.11
Jan-8 49.26 48.50 49.41 48.02

Crinetics Pharmaceuticals Earnings

Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Crinetics Pharmaceuticals Forecast Revenue Growth

Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.